Inspira™ announces breakthrough update: nears first fda 510(k) approval, 3 u.s. patents approved, $546 million in summary distribution agreements

Ra'anana, israel , feb. 27, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) (nasdaq: iinnw) (the "company" or "inspira technologies"), a breakthrough medical technology company, has announced that the company is progressing towards 510(k) clearance from the u.s. food & drug administration ("fda") for its inspira™ art100 in the first half of 2024.
IINN Ratings Summary
IINN Quant Ranking